LexaGene: Automated, Rapid Pathogen Detection

October 27, 2020

MiQLab automated pathogen detection system

LexaGene is a molecular diagnostics company. In fact, they're developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected. Further, the system offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.

More on MiQLab

LexaGene’s MiQLab™ system aims to transform pathogen detection in multi-billion-dollar-markets.

MiQLab brings reference laboratory quality data to the point-of-need where samples are collected—to quickly detect multiple pathogens at once with sensitivity and specificity—and return results in ~1 hour. MiQLab is an automated, multiplexing PCR-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.

For more information on LexaGene Holdings, Inc., (TSX.V: LXG, OTCQB: LXXGF) please fill out the form below.

You might also like

Healthcare
Lexaria Bioscience: The New Biotech Revolution

Lexaria Bioscience is setting new standards in drug delivery with its patented DehydraTECH™ oral technology, optimizing absorption for GLP-1 and other high-demand drugs.

Healthcare
Medicus Pharma: Treatment with Non-Invasive Solutions

Medicus Pharma is transforming skin cancer care with its innovative, non-invasive chemotherapy delivery system, providing a safer and more effective alternative to traditional surgery.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, The Globe and Mail, YouTube and more!